Abiomed Inc (Abiomed) is a medical device company that develops, manufactures, and markets circulatory support devices. The devices replace or assist the pumping function in a failing heart. The company’s heart support and recovery product portfolio includes Impella heart pumps (catheter-based devices including micro heart pumps, expandable catheter pumps and axial flow pumps) and Breethe system (implantable cardiac and respiratory assist devices). Abiomed also offers online clinical support through Impella Connect, on-call assistance and on-site assistance for health workers in hospitals. The company sells its products through direct sales and distributors in South America, Europe, Asia, and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Abiomed Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Abiomed Inc Company Overview
- Abiomed Inc Company Snapshot
- Abiomed Inc Pipeline Products and Ongoing Clinical Trials Overview
- Abiomed Inc - Pipeline Analysis Overview
- Business Description
- Abiomed Inc - Key Facts
- Abiomed Inc - Major Products and Services
- Abiomed Inc Pipeline Products by Development Stage
- Abiomed Inc Ongoing Clinical Trials by Trial Status
- Abiomed Inc Pipeline Products Overview
- AbioCor II
- AbioCor II Product Overview
- Abiomed Breethe OXY-1 System
- Abiomed Breethe OXY-1 System Product Overview
- Abiomed Breethe OXY-1 System Clinical Trial
- Artificial Intelligence Algorithm
- Artificial Intelligence Algorithm Product Overview
- Expandable Sheath - Heart Failure
- Expandable Sheath - Heart Failure Product Overview
- Impecmo
- Impecmo Product Overview
- Impella BTR
- Impella BTR Product Overview
- Impella BTR Clinical Trial
- Impella ECP
- Impella ECP Product Overview
- Impella ECP Clinical Trial
- Impella RP Flex with SmartAssist
- Impella RP Flex with SmartAssist Product Overview
- Impella XC
- Impella XC Product Overview
- Impella XR Sheath With Impella CP
- Impella XR Sheath With Impella CP Product Overview
- Next Generation Impella CP - STEMI
- Next Generation Impella CP - STEMI Product Overview
- Next Generation Impella CP - STEMI Clinical Trial
- Symphony Heart Pump
- Symphony Heart Pump Product Overview
- Abiomed Inc - Key Competitors
- Abiomed Inc - Key Employees
- Abiomed Inc - Key Employee Biographies
- Abiomed Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Abiomed Inc, Recent Developments
- Oct 23, 2023: Abiomed to Highlight Data Analysis Identifying Complex Clinical Profile of Patients Receiving Impella-Supported HRPCI at TCT Symposium
- Aug 17, 2023: Abiomed Recalls the Labeling for Impella RP Flex with SmartAssist for Risk of Blood Clots
- Jul 27, 2023: Abiomed Recalls Nearly 8,000 Devices From Impella Pump Range
- Jul 11, 2023: Abiomed Receives 510(k) Clearance for preCARDIA Occlusion System
- Jun 14, 2023: Class 1 Device Recall Impella 2.5
- Jun 05, 2023: Abiomed Recalls Specific Impella 5.5 with SmartAssist for Purge Fluid Leaks that Can Cause Pump Stop and Loss of Support
- May 18, 2023: Analysis Showcases Potential for More Complete Revascularizations with Impella Compared to IABP During HRPCI
- Apr 25, 2023: Pivotal Impella ECP study expands enrollment to three New Jersey hospitals
- Mar 13, 2023: Breethe receives additional 510(k) clearance for Abiomed Breethe OXY-1 System
- Feb 21, 2023: Breethe Announces Meditation & Stress App Provides Free Memberships to Those Who Have Been Laid Off
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Abiomed Inc Pipeline Products and Ongoing Clinical Trials Overview
- Abiomed Inc Pipeline Products by Equipment Type
- Abiomed Inc Pipeline Products by Indication
- Abiomed Inc Ongoing Clinical Trials by Trial Status
- Abiomed Inc, Key Facts
- Abiomed Inc, Major Products and Services
- Abiomed Inc Number of Pipeline Products by Development Stage
- Abiomed Inc Pipeline Products Summary by Development Stage
- Abiomed Inc Ongoing Clinical Trials by Trial Status
- Abiomed Inc Ongoing Clinical Trials Summary
- AbioCor II - Product Status
- AbioCor II - Product Description
- Abiomed Breethe OXY-1 System - Product Status
- Abiomed Breethe OXY-1 System - Product Description
- Abiomed Breethe OXY-1 System - Breethe Abiomed Recovery Registry (BART)
- Artificial Intelligence Algorithm - Product Status
- Artificial Intelligence Algorithm - Product Description
- Expandable Sheath - Heart Failure - Product Status
- Expandable Sheath - Heart Failure - Product Description
- Impecmo - Product Status
- Impecmo - Product Description
- Impella BTR - Product Status
- Impella BTR - Product Description
- Impella BTR - Use of the Impella BTR in Patients with Heart Failure: An Early Feasibility Study
- Impella ECP - Product Status
- Impella ECP - Product Description
- Impella ECP - Use of the Impella ECP in Patients Undergoing an Elective High-risk Percutaneous Coronary Intervention: An Early Feasibility Study
- Impella ECP - Use of the Impella ECP in Patients Undergoing an Elective or Urgent High-Risk Percutaneous Coronary Intervention Impella ECP Continued Access Protocol
- Impella RP Flex with SmartAssist - Product Status
- Impella RP Flex with SmartAssist - Product Description
- Impella XC - Product Status
- Impella XC - Product Description
- Impella XR Sheath With Impella CP - Product Status
- Impella XR Sheath With Impella CP - Product Description
- Next Generation Impella CP - STEMI - Product Status
- Next Generation Impella CP - STEMI - Product Description
- Next Generation Impella CP - STEMI - Primary Unloading and Delayed Reperfusion in St-elevation Myocardial Infarction: The STEMI-DTU Trial
- Symphony Heart Pump - Product Status
- Symphony Heart Pump - Product Description
- Abiomed Inc, Key Employees
- Abiomed Inc, Key Employee Biographies
- Abiomed Inc, Subsidiaries
- Glossary
- Abiomed Inc Pipeline Products by Equipment Type
- Abiomed Inc Pipeline Products by Development Stage
- Abiomed Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Boston Scientific Corp
- LivaNova Plc
- Edwards Lifesciences Corp
- Medtronic Plc
- Teleflex Inc
- Abbott Laboratories
- Getinge AB
- Terumo Corp
